Drugs Made In America Acquisition II Corp
Research Drugs Made In America Acquisition II Corp (DMII) on Bullrun: market cap USD 649.10M, P/E 50.0. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDMII
- ExchangeNASDAQ
- CountryUnited States
- SectorFinancial Services
- IndustryShell Companies
- CurrencyUSD
- Market capUSD 649.10M
- P/E50.0
- Financial periodQ2 2026
- RevenueUSD 0
- Net incomeUSD 4.40M
- Free cash flow-USD 172.75K
Valuation Snapshot
latest market cap is USD 649.10M; P/E is 50.0.
Peer valuation comparison
Latest P/E is 50.05x versus a Financial Services sector median of 13.41x (273.2% above).
Latest P/E is 50.05x versus a United States median of 23.75x (110.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | USD 4.19M | -USD 1.02M | n/a | 0.15 | USD 223 | USD 297.29K | -USD 17.77M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 649.10M | 50.0 | n/a | n/a |
| 2025 | 2025-12-31 | USD 630.63M | 141.4 | n/a | n/a |
About Drugs Made In America Acquisition II Corp
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.
Related stock research
Other Financial Services stocks
Frequently asked questions
What is Drugs Made In America Acquisition II Corp's market cap?
Drugs Made In America Acquisition II Corp's market capitalization is USD 649.10M.
What is Drugs Made In America Acquisition II Corp's P/E ratio?
Drugs Made In America Acquisition II Corp's price-to-earnings (P/E) ratio is 50.0.
What does Drugs Made In America Acquisition II Corp do?
Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.